Tag Archives: NEW RELEASE

ZandCell Appoints Chief Medical Officer to Accelerate the Execution of International Medical Development Strategies

ZandCell Appoints Chief Medical Officer to Accelerate the Execution of International Medical Development Strategies Stockholm, SWEDEN, March 03, 2020 – ZandCell AB. (“ZandCell” or the “Company”), a biotechnology company focused on the development of therapies for untreatable diseases, is pleased to announce that Professor Doctor Panos Zavos has been appointed the Company’s Chief and Director … Continue reading

2020-03-03 NEWS, News Releases